Advances in bioinformatics, genomics, proteomics, and metabolomics have facilitated the
development of novel anticancer agents that have decreased side effects and increased …

Stimuli-activatable strategies prevail in the design of nanomedicine for cancer theranostics.
Upon exposure to endogenous/exogenous stimuli, the stimuli-activatable nanomedicine …

Materials that respond to endogenous stimuli are being leveraged to enhance
spatiotemporal control in a range of biomedical applications from drug delivery to diagnostic …

For decades, researchers and medical professionals have aspired to develop mechanisms
for noninvasive treatment and monitoring of pathological conditions within the human body …

Stimuli‐responsive materials are so named because they can alter their physicochemical
properties and/or structural conformations in response to specific stimuli. The stimuli can be …

Cancer theranostics combines cancer diagnosis and cancer therapy, aiming for early
diagnosis, accurate molecular imaging, and precise treatment at the right timing and proper …

Smart theranostics are dynamic platforms that integrate multiple functions, including at least
imaging, therapy, and responsiveness, in a single agent. This review showcases a variety of …

Multimodal imaging, which harnesses two or more imaging modalities to produce
complementary anatomical and molecular information of a living subject, has become as a …

Theranostics are nano-size or molecular-level agents serving for both diagnosis and
therapy. Structurally, they are drug delivery systems integrated with molecular or targeted …

Advances in technology and nanomedicine have led to the development of nanoparticles
that can be activated for multimodal imaging of cancer, where a stimulus induces a material …